BNP PARIBAS FINANCIAL MARKETS - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$1,195,438
+7.6%
68,822
-12.7%
0.00%
+100.0%
Q2 2023$1,110,560
-18.4%
78,875
-37.7%
0.00%
-50.0%
Q1 2023$1,361,635
+159.7%
126,546
+261.6%
0.00%
+100.0%
Q4 2022$524,285
-99.6%
34,999
+224.3%
0.00%
Q3 2022$138,569,000
-15.6%
10,792
-36.3%
0.00%
Q2 2022$164,149,000
-73.0%
16,940
-72.3%
0.00%
-100.0%
Q1 2022$608,298,000
-9.2%
61,197
+7.5%
0.00%0.0%
Q4 2021$669,807,000
+944.0%
56,908
+910.3%
0.00%
Q3 2021$64,160,000
+328.8%
5,633
+424.5%
0.00%
Q2 2021$14,961,000
-76.9%
1,074
-69.3%
0.00%
Q1 2021$64,766,000
+18.8%
3,499
+13.4%
0.00%
Q4 2020$54,512,000
-44.3%
3,085
-51.7%
0.00%
Q3 2020$97,895,000
+177.0%
6,390
+360.7%
0.00%
Q2 2020$35,341,000
-49.6%
1,387
-69.4%
0.00%
Q1 2020$70,062,000
+182.5%
4,526
+101.9%
0.00%
Q4 2019$24,797,000
+31.5%
2,242
+1.2%
0.00%
Q3 2019$18,858,000
-9.4%
2,216
+44.2%
0.00%
Q2 2019$20,811,000
-57.1%
1,537
-42.8%
0.00%
Q1 2019$48,491,000
+691.8%
2,685
+1131.7%
0.00%
Q4 2018$6,124,000
+74.0%
218
+58.0%
0.00%
Q3 2018$3,519,0001380.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,374,392$36,376,0004.43%
Opaleye Management Inc. 338,000$8,778,0001.72%
Lion Point Capital, LP 495,748$7,594,0001.67%
Fairmount Funds Management LLC 212,746$3,259,0001.38%
Vivo Capital, LLC 1,151,622$17,643,0001.02%
Spearhead Capital Advisors, LLC 270,117$4,138,0000.79%
Integral Health Asset Management, LLC 120,000$1,838,0000.56%
Endurant Capital Management LP 117,480$1,800,0000.53%
SPHERA FUNDS MANAGEMENT LTD. 259,990$3,983,0000.39%
Ikarian Capital, LLC 342,998$5,254,0000.38%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders